Skip to content

menu

Home About Services Contact
Keller and Heckman LLP logo
Keller and Heckman LLP logo

The Continuum of Risk

A Law Blog for Vapor, Tobacco and Reduced-Harm Product Companies

Epidiolex

Subscribe to Epidiolex
GW PHARM

Supplemental New Drug Application Submitted for FDA-Approved CBD Drug Epidiolex

By Azim Chowdhury & Neelam Gill on February 11, 2020
Posted in CBD, FDA
Photo of Azim ChowdhuryPhoto of Neelam Gill

Reposted from Keller and Heckman’s Blog, The Daily Intake

  • As previously reported in this blog, the 2018 Farm Bill removed hemp – defined as Cannabis sativa L. with less than 0.3% THC on a dry weight basis – from the definition of “marijuana.” As a result, while marijuana remains a Schedule I

…

Stay Connected

LinkedIn RSS Twitter

Blog Authors Show/Hide

  • Azim Chowdhury
  • Keller and Heckman
  • Eric P. Gotting
  • Sheila A. Millar
  • David J. Ettinger
  • LieAnn T. Van-Tull
  • Tracy P. Marshall
  • Neelam Gill
  • John B. Gustafson
  • Natalie E. Rainer
  • Kathryn C. Skaggs
  • Galen D. Rende
  • Jean-Cyril Walker
  • Robert Niemann
  • Cathie Chen
  • Eric Gu
  • Ian J. Murray
  • Caleb Holland
  • Arthur S. Garrett III
  • Manesh K. Rath
  • Mitzi Ng Clark

Topics

Archives

Recent Updates

  • China Publishes Final GB Standard on E-Cigarettes: The Basis for Product Compliance
  • FDA Issues Delta-8 THC Warning Letters
  • FDA Authorizes NJOY ACE Tobacco-Flavored Electronic Nicotine Delivery System (ENDS) Products for Marketing
  • Tobacco Industry Leader Joins Keller and Heckman’s Expanding Tobacco and E-Vapor Practice
  • FDA Authorizes Tobacco-Flavored Logic Technology Electronic Nicotine Delivery System (ENDS) for Marketing & Issues Marketing Denial Orders for Fontem’s myblu ENDS Products

The Continuum of Risk

Keller and Heckman LLP
Boulder Office|Brussels Office|San Francisco Office|Shanghai Office|Washington, DC Office
LinkedIn RSS Twitter
DisclaimerPrivacy and Cookies Policy

About our Firm

Keller and Heckman, founded in 1962, has a broad practice in the areas of regulatory law, public policy, and litigation, serving both domestic and international clients. Our firm is a pioneer in the use of interdisciplinary approaches to problem-solving. Since 1971, we have had an in-house scientific staff that works closely with the firm’s attorneys on matters of technical complexity. Many of our attorneys also have government experience and expertise in multiple areas of the law.

Read More…
Copyright © 2022, Keller and Heckman LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo